New York, March 13, 2018:
Contraceptive Devices Market Forecast 2018 to 2023
The Global Contraceptive Devices Market is expected to exceed more than US$ 16.10 Billion by 2023 at a CAGR of 7.5% in the given forecast period.
The scope of the report includes a detailed study of global and regional markets on Contraceptive Devices Market with the reasons given for variations in the growth of the industry in certain regions.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Cooper Surgical, Inc. (U.S.), Pfizer, Inc. (U.S.), Actavis, Inc. (U.S.), Teva Pharmaceutical Industries Limited (Israel), Bayer AG (Germany), The Female Health Company (U.S.), Merck & Co., Inc. (U.S.), Mayer Laboratories, Inc. (U.S.), Church & Dwight, Co., Inc. (U.S.), Medisafe Distribution Inc. (Canada), and others. Company profile such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
You can browse full report here: https://www.marketresearchengine.com/contraceptive-devices-market
The Global Contraceptive Devices Market has been segmented as below:
By Product Analysis:
By End User Analysis:
- Home Care
- Ambulatory Surgical Centers (ASC)
By Regional Analysis:
- North America
- Rest of the World
This report provides:
1) An overview of the global market for contraceptive Devices and related technologies.
2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2022.
3) Identifications of new market opportunities and targeted promotional plans for Global Contraceptive Devices Market.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
Request Sample Report: https://www.marketresearchengine.com/contraceptive-devices-market
Table of Contents
2 Research Methodology
3 MARKET OVERVIEW
3.2.1. INCREASED RATE OF UNPLANNED PREGNANCIES
3.2.2. RISING NUMBER OF INITIATIVES UNDERTAKEN BY THE PRIVATE FIRMS
3.2.3. FAVOURABLE INSURANCE FOR IUCD’S
3.2.4. GROWING AWARENESS OF CONTRACEPTIVE
3.2.5. GROWING FUNDS AND GRANTS FOR IUCD PRODUCTS
3.2.6. TECHNOLOGICAL ADVANCEMENTS
3.2.1. HIGH COST OF TREATMENT
3.2.2. THREAT OF CAUSING PELVIC INFLAMMOTORY DISEASE (PID)
3.2.3. THREAT CAUSING EPICTAPIC PREGNANCY
3.2.4. CHANGES IN GOVERNMENT REGULATIONS
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
6 GLOBAL CONTRACEPTIVE DEVICES MARKET, BY PRODUCT TYPE
7 GLOBAL CONTRACEPTIVE DEVICES MARKET, BY GEOGRAPHY
8 GLOBAL CONTRACEPTIVE DEVICES MARKET: COMPETITIVE LANDSCAPE
9 GLOBAL CONTRACEPTIVE DEVICES MARKET, COMPANY PROFILES
9.1. BAYER HEALTHCARE AG
9.2. DKT INTERNATIONAL
9.3. TEVA PHARMACEUTICALS INDUSTRIES, LTD
9.4. ALLERGEN, PLC
9.5. SMB CORPORATION
9.6. ACTAVIS PLC.
9.7. OCON MEDICAL LTD.
9.8. MONALISA NV
9.9. MEDISAFE DISTRIBUTION, INC.
9.10.MERIL LIFE SCIENCES PVT. LTD.
Company Name: Market Research Engine
Contact Person: John Bay
Country: United States